← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Young Therapeutics, Llc
Philadelphia, PA
$2,400,160
Total funding
3
Grants
Funding over time
peak $1.5M · FY2019–25$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,400,160 · 3
By mechanism
R44$1,488,899 · 1
R43$911,261 · 2
Investigators at Young Therapeutics, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Minimizing myocardial damage and loss of cardiac function post myocardial infarction using Targeted PKC inhibitors 002 and 004.$1,488,899
R44 · FY2025 · HL
Young, Lindon H$560,261
R43 · FY2021 · HL
The effects of protein kinase C epsilon peptide inhibitor (YT-001) in warm murine kidney ischemia-reperfusion$300,000
R43 · FY2019 · DK
The effects of protein kinase C epsilon peptide inhibitor (YT-001) in warm murine kidney ischemia-reperfusion$51,000
R43 · FY2020 · DK